State Street Corporation 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 07:53 am Sale |
2024-12-31 | 13G | Verve Therapeutics, Inc. VERV |
STATE STREET CORP STT |
3,235,747 3.800% |
-1,017,470 (-23.92%) |
Filing |
| 2024-10-16 1:06 pm Purchase |
2024-09-30 | 13G | Verve Therapeutics, Inc. VERV |
STATE STREET CORP STT |
4,253,217 5.000% |
386,453 (+9.99%) |
Filing |
| 2024-01-23 10:13 am Sale |
2023-12-31 | 13G | Verve Therapeutics, Inc. VERV |
STATE STREET CORP STT |
3,866,764 4.810% |
-604,285 (-13.52%) |
Filing |
| 2023-02-07 1:11 pm Purchase |
2022-12-31 | 13G | Verve Therapeutics, Inc. VERV |
STATE STREET CORP STT |
4,471,049 7.260% |
4,471,049 (New Position) |
Filing |